10 Best Penny Stocks to Buy for the Next 5 Years

7. Autolus Therapeutics plc (NASDAQ:AUTL)

Year-Over-Year Revenue Growth: 185.17%

3-Year Revenue CAGR: 271.89%

Share Price: $1.75

Number of Hedge Fund Holders: 17

Autolus Therapeutics plc (NASDAQ:AUTL) ranks among the best penny stocks to buy for the next 5 years. On August 12, Needham reiterated a Buy rating on Autolus Therapeutics plc (NASDAQ:AUTL) with a $10 price target.

This decision came after Autolus Therapeutics plc (NASDAQ:AUTL) shared results for the second quarter of 2025.

The company had a strong second quarter, with $20.9 million in net product revenue from its product AUCATZYL, beating both Needham’s and market estimates. As a result, the firm raised its revenue estimates for Autolus Therapeutics plc (NASDAQ:AUTL) for 2025 and 2026.

Additionally, Autolus Therapeutics plc (NASDAQ:AUTL) is growing its Activated Treatment Centers (ATCs), increasing the number of centers to 46 as of August 12, 2025. The company aims to have over 50 centers by the end of the year.

Autolus Therapeutics plc (NASDAQ:AUTL) is an early commercial-stage biopharmaceutical company focused on developing and delivering next-generation T cell therapies for cancer and autoimmune diseases.